Matches in Wikidata for { <http://www.wikidata.org/entity/Q98603696> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q98603696 description "clinical trial" @default.
- Q98603696 description "ensayo clínico" @default.
- Q98603696 description "ensayu clínicu" @default.
- Q98603696 description "klinisch onderzoek" @default.
- Q98603696 description "клінічне випробування" @default.
- Q98603696 description "临床试验" @default.
- Q98603696 name "A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19" @default.
- Q98603696 name "A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19" @default.
- Q98603696 type Item @default.
- Q98603696 label "A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19" @default.
- Q98603696 label "A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19" @default.
- Q98603696 prefLabel "A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19" @default.
- Q98603696 prefLabel "A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19" @default.
- Q98603696 P1132 Q98603696-1992FC01-3D12-45A2-9178-B76A5F5760D9 @default.
- Q98603696 P1476 Q98603696-3EECDE9F-710B-418D-8CD4-625E3BA25C59 @default.
- Q98603696 P2899 Q98603696-7A5DD111-6F63-4A82-9052-DD38535D9CA0 @default.
- Q98603696 P3098 Q98603696-396F6160-40DB-4501-862C-596599469EF4 @default.
- Q98603696 P31 Q98603696-32190463-844E-46E1-84CA-5B6D32504DFA @default.
- Q98603696 P4135 Q98603696-8A2EFAB2-2428-454B-8B04-9417C023D034 @default.
- Q98603696 P580 Q98603696-19EE1400-B1F0-45A5-B644-35FFFA837D81 @default.
- Q98603696 P582 Q98603696-8CDB76B7-C721-45D5-89D7-97C54F64D022 @default.
- Q98603696 P6099 Q98603696-AAB3001C-D276-49BF-BF42-C334D342FC7A @default.
- Q98603696 P8005 Q98603696-CE0CE168-FB4A-4452-A441-43EB14AF0994 @default.
- Q98603696 P8363 Q98603696-2C8F060D-2FE9-4D0B-A875-BEE75ED0350E @default.
- Q98603696 P1132 "+118" @default.
- Q98603696 P1476 "A Multicenter, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of XC221, Tablets, 100 mg in Patients With COVID-19" @default.
- Q98603696 P2899 "+18" @default.
- Q98603696 P3098 "NCT04487574" @default.
- Q98603696 P31 Q30612 @default.
- Q98603696 P4135 "+75" @default.
- Q98603696 P580 "2020-07-01T00:00:00Z" @default.
- Q98603696 P582 "2020-12-01T00:00:00Z" @default.
- Q98603696 P6099 Q42824827 @default.
- Q98603696 P8005 Q76649614 @default.
- Q98603696 P8363 Q78089383 @default.